AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2017
Jul 27, 2017
31708_dirs_2017-07-27_4a982da9-5f0b-4205-9637-ab415c871aa8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2017-07-25
Reporting Person: Pellegrino Joseph P JR (Director, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-25 | Common Stock | M | 5 | — | Acquired | 114817 | Direct |
| 2017-07-25 | Common Stock | F | 289 | $28.58 | Disposed | 114528 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-25 | Dividend Equivalent Rights | $ | M | 5 | Disposed | Common Stock (5) | Direct |
Footnotes
F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.